These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 9469432

  • 1. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 2. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H.
    J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644
    [Abstract] [Full Text] [Related]

  • 3. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z.
    Mol Immunol; 2005 May 15; 42(9):1023-31. PubMed ID: 15829292
    [Abstract] [Full Text] [Related]

  • 4. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 5. FLT3-ligand administration inhibits liver metastases: role of NK cells.
    Péron JM, Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR.
    J Immunol; 1998 Dec 01; 161(11):6164-70. PubMed ID: 9834102
    [Abstract] [Full Text] [Related]

  • 6. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
    Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ.
    J Immunol; 1994 Aug 15; 153(4):1697-706. PubMed ID: 7913943
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M, Falk W, Echtenacher B, Männel DN.
    Eur Cytokine Netw; 1999 Dec 15; 10(4):541-8. PubMed ID: 10586121
    [Abstract] [Full Text] [Related]

  • 8. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T, Harada M, Tamada K, Abe K, Nomoto K.
    Anticancer Res; 1997 Dec 15; 17(6D):4259-68. PubMed ID: 9494518
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M.
    Cancer Res; 1997 Oct 15; 57(20):4557-63. PubMed ID: 9377569
    [Abstract] [Full Text] [Related]

  • 10. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
    Comes A, Di Carlo E, Musiani P, Rosso O, Meazza R, Chiodoni C, Colombo MP, Ferrini S.
    Eur J Immunol; 2002 Jul 15; 32(7):1914-23. PubMed ID: 12115611
    [Abstract] [Full Text] [Related]

  • 11. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
    Kawamura T, Seki S, Takeda K, Narita J, Ebe Y, Naito M, Hiraide H, Abo T.
    Cell Immunol; 1999 May 01; 193(2):219-25. PubMed ID: 10222065
    [Abstract] [Full Text] [Related]

  • 13. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Yamaguchi N, Yagita H, Okumura K.
    Cell Immunol; 2001 Dec 15; 214(2):194-200. PubMed ID: 12088418
    [Abstract] [Full Text] [Related]

  • 14. Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction.
    Ogasawara K, Takeda K, Hashimoto W, Satoh M, Okuyama R, Yanai N, Obinata M, Kumagai K, Takada H, Hiraide H, Seki S.
    J Immunol; 1998 Apr 01; 160(7):3522-7. PubMed ID: 9531314
    [Abstract] [Full Text] [Related]

  • 15. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H, Horikawa T, Hara I, Fukunaga A, Oniki S, Oka M, Nishigori C, Ichihashi M.
    Exp Dermatol; 2004 Oct 01; 13(10):613-20. PubMed ID: 15447721
    [Abstract] [Full Text] [Related]

  • 16. Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness.
    Balkhy HH, Heinzel FP.
    J Immunol; 1999 Mar 15; 162(6):3633-8. PubMed ID: 10092824
    [Abstract] [Full Text] [Related]

  • 17. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
    Wang G, Tschoi M, Spolski R, Lou Y, Ozaki K, Feng C, Kim G, Leonard WJ, Hwu P.
    Cancer Res; 2003 Dec 15; 63(24):9016-22. PubMed ID: 14695220
    [Abstract] [Full Text] [Related]

  • 18. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
    Redlinger RE, Shimizu T, Remy T, Alber S, Watkins SC, Barksdale EM.
    J Pediatr Surg; 2003 Feb 15; 38(2):199-204. PubMed ID: 12596103
    [Abstract] [Full Text] [Related]

  • 19. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
    Komita H, Homma S, Saotome H, Zeniya M, Ohno T, Toda G.
    J Hepatol; 2006 Nov 15; 45(5):662-72. PubMed ID: 16935390
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.
    Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X.
    Gene Ther; 2000 Oct 15; 7(19):1672-9. PubMed ID: 11083476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.